Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice

The Zika virus envelope protein glycan loop regulates virion antigenicity

(2018) Leslie Goo et al.   VIROLOGY

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

(2017) Norbert Pardi et al.   NATURE

Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus

(2017) Ming Yang et al.   VACCINE

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon

(2017) Darci R. Smith et al.   PLoS Neglected Tropical Diseases

Zika virus-like particle (VLP) based vaccine

(2017) Hélène Boigard et al.   PLoS Neglected Tropical Diseases

Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice

(2017) Ryan D. Pardy et al.   PLoS Pathogens

Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells

(2017) Jinsheng Wen et al.   Nature Microbiology

Protective efficacy of Zika vaccine in AG129 mouse model

(2017) K. Sumathy et al.   Scientific Reports

Immunization with truncated envelope protein of Zika virus induces protective immune response in mice

(2017) Jian-Feng Han et al.   Scientific Reports

Structural Basis of Zika Virus-Specific Antibody Protection

(2016) Haiyan Zhao et al.   CELL

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

(2016) Lianpan Dai et al.   Cell Host & Microbe

A Mouse Model of Zika Virus Pathogenesis

(2016) Helen M. Lazear et al.   Cell Host & Microbe

Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission

(2016) Takako Tabata et al.   Cell Host & Microbe

Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice

(2016) Dapeng Li et al.   JOURNAL OF VIROLOGY

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

(2016) Van-Mai Cao-Lormeau et al.   LANCET

Zika virus: history of a newly emerging arbovirus

(2016) Nitwara Wikan et al.   LANCET INFECTIOUS DISEASES

Structure of the thermally stable Zika virus

(2016) Victor A. Kostyuchenko et al.   NATURE

Vaccine protection against Zika virus from Brazil

(2016) Rafael A. Larocca et al.   NATURE

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

(2016) Gopal Sapparapu et al.   NATURE

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

(2016) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

Zika viral dynamics and shedding in rhesus and cynomolgus macaques

(2016) Christa E Osuna et al.   NATURE MEDICINE

Zika Virus Associated with Microcephaly

(2016) Jernej Mlakar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evidence of Sexual Transmission of Zika Virus

(2016) Eric D’Ortenzio et al.   NEW ENGLAND JOURNAL OF MEDICINE

One year later, Zika scientists prepare for a long war

(2016) G. Vogel   SCIENCE

Rapid development of a DNA vaccine for Zika virus

(2016) K. A. Dowd et al.   SCIENCE

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

(2016) P. Abbink et al.   SCIENCE

Zika virus in the Americas: Early epidemiological and genetic findings

(2016) N. R. Faria et al.   SCIENCE

The 3.8 A resolution cryo-EM structure of Zika virus

(2016) D. Sirohi et al.   SCIENCE

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

(2016) Q. Wang et al.   Science Translational Medicine

Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation

(2016) Eun Kim et al.   EBioMedicine

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

(2016) Karuppiah Muthumani et al.   npj Vaccines

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine

(2014) Hui Zhao et al.   PLoS One

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

(2010) Martina Beltramello et al.   Cell Host & Microbe

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

(2010) Feng-Cai Zhu et al.   LANCET

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

(2009) Mark R. Duffy et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Mannose Receptor Mediates Dengue Virus Infection of Macrophages

(2008) Joanna L. Miller et al.   PLoS Pathogens